UNCOVERED: Nvcr - The Untold Story

Looking Into NovoCure's Return On Capital Employed

According to data from Benzinga Pro, during Q1, NovoCure's (NASDAQ:NVCR) reported sales totaled $137.55 million. Despite a 82.44% increase in earnings, the company posted a loss of $4.65 million.

Benzinga · May 5, 2022

NovoCure: Q1 Earnings Insights

  NovoCure (NASDAQ:NVCR) reported its Q1 earnings results on Thursday, April 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Benzinga · Apr 28, 2022

Novocure's TTFields Show Improved Progression-Free, Overall Survival Over Matched-Control

Novocure Ltd (NASDAQ: NVCR) 

Benzinga · Mar 25, 2022